Payment overview · 2025
General Payments
$15.73
1 reported records · 1 companies
Healthcare provider profile · identity verified
Angela N Cade, MD
Allopathic & Osteopathic Physicians|Family Medicine · TYLER, TX · NPI 1447486691
Verified facts
What the public records show
CMS Open Payments records show Angela N Cade, MD received $15.73 in general payments during 2025 across 1 reported records.
Stryker Corporation accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Stryker Corporation | Unresolved — no canonical attribution shown | $15.73 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $15.73 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| 1788 Normalized: 1788 |
Medical Supply | Stryker Corporation | $15.73 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 629 | 168 |
| Amlodipine Besylate | Amlodipine Besylate | 578 | 177 |
| Atorvastatin Calcium | Atorvastatin Calcium | 510 | 152 |
| Gabapentin | Gabapentin | 419 | 125 |
| Losartan Potassium | Losartan Potassium | 412 | 135 |
| Lisinopril | Lisinopril | 362 | 116 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 336 | 112 |
| Hydrochlorothiazide | Hydrochlorothiazide | 271 | 99 |
| Omeprazole | Omeprazole | 267 | 77 |
| Pantoprazole Sodium | Pantoprazole Sodium | 243 | 86 |
| Simvastatin | Simvastatin | 228 | 67 |
| Metformin Hcl | Metformin Hcl | 225 | 75 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 222 | 37 |
| Metoprolol Succinate | Metoprolol Succinate | 222 | 72 |
| Tramadol Hcl | Tramadol Hcl | 211 | 57 |
| Escitalopram Oxalate | Escitalopram Oxalate | 206 | 55 |
| Pravastatin Sodium | Pravastatin Sodium | 204 | 60 |
| Trazodone Hcl | Trazodone Hcl | 197 | 63 |
| Montelukast Sodium | Montelukast Sodium | 189 | 59 |
| Zolpidem Tartrate | Zolpidem Tartrate | 184 | 41 |
| Mounjaro | Tirzepatide | 167 | 26 |
| Sertraline Hcl | Sertraline Hcl | 162 | 47 |
| Jardiance | Empagliflozin | 159 | 41 |
| Potassium Chloride | Potassium Chloride | 155 | 59 |
| Furosemide | Furosemide | 150 | 53 |
| Carvedilol | Carvedilol | 148 | 48 |
| Amitriptyline Hcl | Amitriptyline Hcl | 146 | 45 |
| Tamsulosin Hcl | Tamsulosin Hcl | 145 | 54 |
| Pregabalin | Pregabalin | 138 | 37 |
| Metoprolol Tartrate | Metoprolol Tartrate | 131 | 37 |
| Meloxicam | Meloxicam | 128 | 39 |
| Donepezil Hcl | Donepezil Hcl | 122 | 34 |
| Duloxetine Hcl | Duloxetine Hcl | 121 | 40 |
| Alprazolam | Alprazolam | 119 | 28 |
| Alendronate Sodium | Alendronate Sodium | 115 | 37 |
| Ezetimibe | Ezetimibe | 115 | 37 |
| Glimepiride | Glimepiride | 114 | 36 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 112 | 32 |
| Clonazepam | Clonazepam | 105 | 19 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 104 | 44 |
| Metformin Hcl Er | Metformin Hcl | 103 | 34 |
| Ropinirole Hcl | Ropinirole Hcl | 102 | 31 |
| Fluticasone Propionate | Fluticasone Propionate | 101 | 41 |
| Ondansetron Odt | Ondansetron | 96 | 39 |
| Spironolactone | Spironolactone | 90 | 26 |
| Buspirone Hcl | Buspirone Hcl | 89 | 25 |
| Temazepam | Temazepam | 89 | 15 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 86 | 20 |
| Ibandronate Sodium | Ibandronate Sodium | 82 | 31 |
| Allopurinol | Allopurinol | 79 | 25 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 78 | 22 |
| Hydralazine Hcl | Hydralazine Hcl | 77 | 23 |
| Synthroid | Levothyroxine Sodium | 76 | 25 |
| Clonidine Hcl | Clonidine Hcl | 75 | 21 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 73 | 23 |
| Memantine Hcl | Memantine Hcl | 73 | 20 |
| Bupropion Xl | Bupropion Hcl | 72 | 21 |
| Eliquis | Apixaban | 70 | 22 |
| Ozempic | Semaglutide | 69 | 17 |
| Fluoxetine Hcl | Fluoxetine Hcl | 67 | 19 |
| Methocarbamol | Methocarbamol | 64 | 20 |
| Pioglitazone Hcl | Pioglitazone Hcl | 64 | 22 |
| Citalopram Hbr | Citalopram Hydrobromide | 63 | 23 |
| Clopidogrel | Clopidogrel Bisulfate | 63 | 18 |
| Prednisone | Prednisone | 63 | 53 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 63 | 17 |
| Cefuroxime | Cefuroxime Axetil | 62 | 42 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 62 | 20 |
| Valacyclovir | Valacyclovir Hcl | 61 | 15 |
| Glipizide | Glipizide | 57 | 16 |
| Paroxetine Hcl | Paroxetine Hcl | 57 | 21 |
| Tizanidine Hcl | Tizanidine Hcl | 56 | 24 |
| Celecoxib | Celecoxib | 51 | 18 |
| Fluconazole | Fluconazole | 51 | 29 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 48 | 11 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 48 | 14 |
| Topiramate | Topiramate | 47 | 14 |
| Fenofibrate | Fenofibrate | 46 | 12 |
| Estradiol | Estradiol | 45 | 20 |
| Warfarin Sodium | Warfarin Sodium | 43 | 11 |
| Lorazepam | Lorazepam | 42 | suppressed |
| Rybelsus | Semaglutide | 41 | 12 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 40 | 12 |
| Ipratropium Bromide | Ipratropium Bromide | 40 | 12 |
| Trulicity | Dulaglutide | 40 | suppressed |
| Verapamil Er | Verapamil Hcl | 39 | 11 |
| Tresiba Flextouch U-100 | Insulin Degludec | 37 | suppressed |
| Azithromycin | Azithromycin | 36 | 34 |
| Chlorthalidone | Chlorthalidone | 36 | 14 |
| Januvia | Sitagliptin Phosphate | 36 | 11 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 35 | 13 |
| Propranolol Hcl | Propranolol Hcl | 35 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 35 | suppressed |
| Ibuprofen | Ibuprofen | 34 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 33 | 25 |
| Enalapril Maleate | Enalapril Maleate | 33 | suppressed |
| Mirtazapine | Mirtazapine | 33 | 12 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 32 | 25 |
| Dicyclomine Hcl | Dicyclomine Hcl | 32 | 16 |
| Finasteride | Finasteride | 30 | 11 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 29 | 12 |
| Xarelto | Rivaroxaban | 29 | suppressed |
| Rizatriptan | Rizatriptan Benzoate | 28 | suppressed |
| Atenolol | Atenolol | 27 | suppressed |
| Baclofen | Baclofen | 27 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 27 | suppressed |
| Repatha Sureclick | Evolocumab | 26 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 25 | suppressed |
| Nystatin | Nystatin | 25 | 11 |
| Azelastine Hcl | Azelastine Hcl | 24 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 24 | 17 |
| Mupirocin | Mupirocin | 24 | 14 |
| Lovastatin | Lovastatin | 23 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 23 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 23 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 23 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 23 | suppressed |
| Cephalexin | Cephalexin | 22 | 17 |
| Diazepam | Diazepam | 22 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 22 | suppressed |
| Primidone | Primidone | 22 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 22 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 21 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 20 | suppressed |
| Glipizide Er | Glipizide | 20 | suppressed |
| Acyclovir | Acyclovir | 19 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 19 | suppressed |
| Dropsafe Prep Pads | Alcohol Antiseptic Pads | 19 | suppressed |
| Myrbetriq | Mirabegron | 19 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 19 | 11 |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 19 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 18 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 18 | suppressed |
| Bumetanide | Bumetanide | 17 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 17 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 17 | suppressed |
| Klor-Con M20 | Potassium Chloride | 17 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 17 | 12 |
| Torsemide | Torsemide | 17 | suppressed |
| Famotidine | Famotidine | 16 | suppressed |
| Nabumetone | Nabumetone | 16 | suppressed |
| Nifedipine Er | Nifedipine | 16 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 16 | suppressed |
| Valsartan | Valsartan | 16 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 16 | suppressed |
| Amoxicillin | Amoxicillin | 15 | 11 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 15 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 15 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 15 | suppressed |
| Premarin | Estrogens, Conjugated | 15 | suppressed |
| Aripiprazole | Aripiprazole | 14 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 14 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 14 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 14 | 14 |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 14 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 13 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 13 | suppressed |
| Ketorolac Tromethamine | Ketorolac Tromethamine | 13 | suppressed |
| Ramipril | Ramipril | 13 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 13 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 13 | suppressed |
| Butalbital-Aspirin-Caffeine | Butalbital/Aspirin/Caffeine | 12 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 12 | suppressed |
| Irbesartan | Irbesartan | 12 | suppressed |
| Novolin N | Insulin Nph Human Isophane | 12 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 12 | suppressed |
| Amlodipine-Valsartan | Amlodipine Besylate/Valsartan | 11 | suppressed |
| Azelastine-Fluticasone | Azelastine/Fluticasone | 11 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 11 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 11 | suppressed |
| Glipizide-Metformin | Glipizide/Metformin Hcl | 11 | suppressed |
| Ketoconazole | Ketoconazole | 11 | suppressed |
| Methimazole | Methimazole | 11 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 11 | suppressed |
| Veozah | Fezolinetant | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $15.73 · 1 records | Stryker Corporation | 1788 | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error